The company plans to launch operations in the USA throughout the second half of 2021 by launching centers of excellence for robotic-guided interventional procedures and establishing commercial partnerships with third-parties that look for a robotic offering to their customers. On how Micromate fulfils its role within his practice, Van Strijen begins by acknowledging that for any percutaneous biopsy it is very important to have a stable needle, and therefore, a device that helps you keep the needle stable while advancing the device through the skin to the desired target, such as Micromate does, is valuable. The proven submillimeter accuracy and affordable price make it the most seasoned choice for any institution that is looking for new technology in order to improve the outcomes of interventional procedures”, he adds. “We are sure our product is bound to democratize medical robotics in the US. Variable Sample Rates: 1024, 2048, and 4096 samples per second (S/s) for each channel. Touch Screen: Large, high resolution color graphics touch screen. “After a successful start with our partners in Europe and over ten years of experience in medical robotics, we decided it was about time we reached the other side of the pond”, states Michael Vogele, Interventional Systems’ founder and CEO. USB Connectivity for downloading events and to connect to external devices such as powered USB Hubs, Modems, Memory sticks, Printers or a GPS. It is not trivial to develop a full-fledged robotic platform that puts surgeons in charge of so many different procedures with the same core technology, while ensuring a seamless integration into the clinical workflow”, states Pedro Costa, Interventional Systems CPO. “We appreciate the partnership developed with the FDA to rigorously validate safety and accuracy. Targeting is performed under live imaging using any Cone-Beam Computerized Tomography (CT), Fluoro CT or a Fluoroscope. Micromate™ is a table-mounted medical robot for interventional procedures with a universal instrument guidance solution that allows physicians to continue using their preferred surgical instruments. Interventional Systems announced Micromate™, the world’s smallest robot for percutaneous procedures, received its FDA 510(k) clearance, allowing the robotics company to operate in the USA.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |